JPY 2665.0
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Revenue | 10.65 Billion | 9.89 Billion | 7.63 Billion | 10.96 Billion | 11.7 Billion |
Cost of Revenue | 9.47 Billion | 8.82 Billion | 6.8 Billion | 9.27 Billion | 10.65 Billion |
Gross Profit | 1.18 Billion | 1.07 Billion | 833 Million | 1.68 Billion | 1.04 Billion |
Operating Expenses | 948 Million | 924 Million | 931 Million | 1.03 Billion | 903 Million |
Selling, General and Administrative Expenses | 947 Million | 923 Million | 930 Million | 1.03 Billion | 900 Million |
Research and Development Expenses | - | - | - | - | - |
Other Expenses | 948 Million | 31 Million | 33 Million | 51 Million | -3 Million |
Cost and Expenses | 10.42 Billion | 9.75 Billion | 7.73 Billion | 10.31 Billion | 11.55 Billion |
Operating Income | 238 Million | 146 Million | -99 Million | 649 Million | 143 Million |
Interest Expense | - | - | 1 Million | 1 Million | 1 Million |
Income Tax Expense | 135 Million | 107 Million | 19 Million | 258 Million | 118 Million |
Earnings before Tax | 417 Million | 300 Million | 60 Million | 766 Million | 292 Million |
Net Income | 270 Million | 190 Million | 45 Million | 503 Million | 188 Million |
Earnings Per Share Basic | 125.24 | 88.35 | 20.82 | 225.14 | 68.72 |
Earnings Per Share Diluted | 125.24 | 88.35 | 20.82 | 225.14 | 68.72 |
Weighted Average Shares Outstanding | 2.15 Million | 2.15 Million | 2.15 Million | 2.23 Million | 2.73 Million |
Weighted Average Shares Outstanding (Diluted) | 2.15 Million | 2.15 Million | 2.15 Million | 2.23 Million | 2.73 Million |
Gross Margin | 0.11 | 0.11 | 0.11 | 0.15 | 0.09 |
EBIT Margin | 0.03 | 0.04 | 0.01 | 0.08 | 0.02 |
Profit Margin | 0.03 | 0.02 | 0.01 | 0.05 | 0.02 |
EBITDA | 306 Million | 216 Million | -25 Million | 721 Million | 221 Million |
Earnings Before Tax Margin | 0.02 | 0.01 | -0.01 | 0.06 | 0.01 |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Revenue | 1.9 Billion | 3.76 Billion | 10.65 Billion | 3.37 Billion | 2.69 Billion | 2.13 Billion |
Cost of Revenue | 1.73 Billion | 3.14 Billion | 9.47 Billion | 3.02 Billion | 2.36 Billion | 2.02 Billion |
Gross Profit | 170 Million | 620 Million | 1.18 Billion | 349 Million | 327 Million | 110 Million |
Operating Expenses | 239 Million | 230 Million | 948 Million | 265 Million | 227 Million | 232 Million |
Selling, General and Administrative Expenses | 239 Million | 230 Million | - | 264 Million | 227 Million | 232 Million |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | 6 Million | 8 Million | 30 Million | 7 Million | 8 Million | 6 Million |
Cost and Expenses | 1.96 Billion | 3.37 Billion | 10.42 Billion | 3.28 Billion | 2.59 Billion | 2.25 Billion |
Operating Income | -69 Million | 389 Million | 238 Million | 84 Million | 100 Million | -122 Million |
Interest Expense | - | - | - | - | - | - |
Income Tax Expense | 9 Million | 137 Million | 135 Million | 40 Million | 39 Million | -15 Million |
Earnings before Tax | 37 Million | 392 Million | 417 Million | 132 Million | 126 Million | -26 Million |
Net Income | 27 Million | 242 Million | 270 Million | 89 Million | 90 Million | -11 Million |
Earnings Per Share Basic | 12.52 | 112.12 | - | 41.29 | 41.75 | -5.10 |
Earnings Per Share Diluted | 12.52 | 112.12 | - | 41.29 | 41.75 | -5.10 |
Weighted Average Shares Outstanding | 2.15 Million | 2.15 Million | 2.15 Million | 2.15 Million | 2.15 Million | 2.15 Million |
Weighted Average Shares Outstanding (Diluted) | 2.15 Million | 2.15 Million | 2.15 Million | 2.15 Million | 2.15 Million | 2.15 Million |
Gross Margin | 0.09 | 0.16 | 0.11 | 0.10 | 0.12 | 0.05 |
EBIT Margin | -0.03 | 0.10 | - | 0.04 | 0.05 | -0.01 |
Profit Margin | 0.01 | 0.06 | 0.03 | 0.03 | 0.03 | -0.01 |
EBITDA | -49 Million | 390 Million | - | 131 Million | 126 Million | -30 Million |
Earnings Before Tax Margin | -0.04 | 0.10 | 0.02 | 0.02 | 0.04 | -0.06 |
SANGHVIMOV
ALKYLAMINE
LAURUSLABS
EVKRF
URLOF
GULFPETRO